- Home
- Publications
- Publication Search
- Publication Details
Title
GLP-1 and Amylin in the Treatment of Obesity
Authors
Keywords
Amylin, Dual agonist, GLP-1, Obesity treatment, Phybrid
Journal
Current Diabetes Reports
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-23
DOI
10.1007/s11892-015-0693-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incretin-based therapies: where will we be 50 years from now?
- (2015) Juris J. Meier et al. DIABETOLOGIA
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incretins and Amylin: Neuroendocrine Communication Between the Gut, Pancreas, and Brain in Control of Food Intake and Blood Glucose
- (2014) Matthew R. Hayes et al. Annual Review of Nutrition
- Orals
- (2014) DIABETES
- Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
- (2014) Erin E. Mulvihill et al. ENDOCRINE REVIEWS
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: Differences and similarities
- (2014) Asger Lund et al. European Journal of Internal Medicine
- Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes – focus on pancreatitis and pancreas cancer
- (2014) Thor Chalmer et al. Expert Opinion On Drug Safety
- Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight
- (2014) Laurie L. Baggio et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery
- (2014) Sten Madsbad et al. Lancet Diabetes & Endocrinology
- Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health
- (2014) Alexander D Miras et al. Lancet Diabetes & Endocrinology
- Emerging combinatorial hormone therapies for the treatment of obesity and T2DM
- (2013) Sharon A. Sadry et al. Nature Reviews Endocrinology
- Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli
- (2013) Daniela Züger et al. PHYSIOLOGY & BEHAVIOR
- Improved Glucose Control and Reduced Body Weight in Rodents with Dual Mechanism of Action Peptide Hybrids
- (2013) James L. Trevaskis et al. PLoS One
- Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
- (2013) B. Finan et al. Science Translational Medicine
- Amylin and the regulation of appetite and adiposity
- (2013) Jonathan D. Roth Current Opinion in Endocrinology Diabetes and Obesity
- The interaction of amylin with other hormones in the control of eating
- (2012) T. A. Lutz DIABETES OBESITY & METABOLISM
- The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice
- (2012) K. Fosgerau et al. DIABETES OBESITY & METABOLISM
- Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass
- (2012) C. Dirksen et al. DIABETOLOGIA
- Anti-obesity drugs: past, present and future
- (2012) R. J. Rodgers et al. Disease Models & Mechanisms
- Unraveling oxyntomodulin, GLP1's enigmatic brother
- (2012) Alessandro Pocai JOURNAL OF ENDOCRINOLOGY
- GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities
- (2011) Jonathan D Roth et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability
- (2011) A. J. Garber DIABETES CARE
- Amylin and leptin activate overlapping signalling pathways in an additive manner in mouse GT1-7 hypothalamic, C2C12 muscle and AML12 liver cell lines
- (2011) H.-S. Moon et al. DIABETOLOGIA
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
- (2011) A Astrup et al. INTERNATIONAL JOURNAL OF OBESITY
- Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates
- (2010) Nicholas T. Bello et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Leptin and Amylin Act in an Additive Manner to Activate Overlapping Signaling Pathways in Peripheral Tissues: In vitro and ex vivo studies in humans
- (2010) H.-S. Moon et al. DIABETES CARE
- Current and Future Drug Targets in Weight Management
- (2010) Renger F. Witkamp PHARMACEUTICAL RESEARCH
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
- (2009) A. Pocai et al. DIABETES
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Insights from the Liraglutide Clinical Development Program—the Liraglutide Effect and Action in Diabetes (LEAD) Studies
- (2009) Janet B. McGill POSTGRADUATE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now